Therapeutic Classes/Androgen Receptor Inhibitor

Androgen Receptor Inhibitor

7 drugs across 4 manufacturers|6 Generic,1 Brand

The Androgen Receptor Inhibitor class contains 7 NDCs from 4 manufacturers (6 generic, 1 brand), at an average NADAC of $1.78 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.

Total Drugs

7

6G / 1B

Manufacturers

4

Avg $1.7788/unit

Avg 7d Change

-1.39%

Across 5 drugs with changes

7d Activity

1↑4↓2 flat

of 7 total drugs

Class Price Trend

Monthly average NADAC price per unit, split by generic and brand

Drug Portfolio

7 drugs total, 7 shown

Drug ↕Price 7d Change ↕
WINLEVI 1% CREAM
Clascoterone
$10.0010
per GM
+0.08%
BICALUTAMIDE 50 MG TABLET
Bicalutamide
$0.4300
per EA
—
BICALUTAMIDE 50 MG TABLET
Bicalutamide
$0.4044
per EA
-2.86%
BICALUTAMIDE 50 MG TABLET
Bicalutamide
$0.4044
per EA
-2.86%
BICALUTAMIDE 50 MG TABLET
bicalutamide
$0.4044
per EA
-2.86%
BICALUTAMIDE 50 MG TABLET
bicalutamide
$0.4044
per EA
-2.86%
BICALUTAMIDE 50 MG TABLET
Bicalutamide
$0.4028
per EA
—

Follow this class across the site

These links connect the therapeutic class page to the specific suppliers, markets, and trend surfaces that help users keep exploring.

Frequently Asked Questions

How many drugs are in the Androgen Receptor Inhibitor class?

The Androgen Receptor Inhibitor class contains 7 NDCs from 4 manufacturers — 6 generic and 1 brand product.

What is the average price of Androgen Receptor Inhibitor drugs?

The average NADAC for the Androgen Receptor Inhibitor class is $1.7788 per unit across 7 NDCs.

Which manufacturers make Androgen Receptor Inhibitor drugs?

4 manufacturers make drugs in the Androgen Receptor Inhibitor class. Ranked by number of NDCs, the largest are Sun Pharmaceutical Industries Inc. (3), Accord Healthcare Inc. (2), ANI Pharmaceuticals, Inc. (1), Major Pharmaceuticals (1).

How has Androgen Receptor Inhibitor pricing changed recently?

Over the past 7 days, 1 NDC in this class rose and 4 fell, with a class-wide average change of -1.4%.